Rarebreed Veterinary Partners, a network of 33 clinics scattered across the Northeastern United States, has raised an undisclosed amount of money to support the acquisition of more practices.
The private equity firms Halle Capital Management and Trilantic North America, which purchased minority stakes in Rarebreed in September 2020, invested additional sums during the latest financing round. Details were not released.
“We are excited to announce this new round of funding, which will allow us to continue providing an exceptional work experience for animal health care professionals in our network, while expanding our platform to reach even more people who have dedicated their professional lives to veterinary care,” said Dan Espinal, MBA, Rarebreed’s CEO and co-founder.
Espinal and chief operating officer Sean Miller, MBA, “retain meaningful equity stakes in the business and will continue to lead the company through its next phase of growth,” Rarebreed stated.
The Portland, Maine-based company purchases existing clinics and keeps the clinics’ staff and culture in place. Rarebreed focuses on back-office support such as human resources, finance, marketing and strategic planning.
The 3-year-old company has nearly doubled in size in eight months, growing from 17 clinics in September 2020, when Halle and Trilantic acquired their initial shares.
In other news, Rarebreed added Christina V. Tran, DVM, to its board of directors. Dr. Tran is an associate professor and clinical relations lead veterinarian at the University of Arizona College of Veterinary Medicine. She previously served as the veterinary technology program director at the Purdue University College of Veterinary Medicine.
Did you know a subscription to Today’s Veterinary Business is free to qualified veterinary professionals? All you have to do is sign up here (and renew each year). You also can sign up to receive the Today’s Veterinary Business weekly e-newsletter.